Effect of rivaroxaban and aspirin in patients with peripheral artery disease undergoing surgical revascularization: insights from the VOYAGER PAD trial
ES Debus, MR Nehler, N Govsyeyev, RM Bauersachs… - Circulation, 2021 - Am Heart Assoc
Background: Patients with peripheral artery disease requiring lower extremity
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
[PDF][PDF] Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial
ES Debus, MR Nehler, N Govsyeyev… - Circulation, 2021 - researchgate.net
BACKGROUND: Patients with peripheral artery disease requiring lower extremity
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial
E Debus, M Nehler, N Govsyeyev… - CIRCULATION …, 2021 - irinsubria.uninsubria.it
Background: Patients with peripheral artery disease requiring lower extremity
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial
ES Debus, MR Nehler, N Govsyeyev, RM Bauersachs… - Circulation, 2021 - Am Heart Assoc
BACKGROUND: Patients with peripheral artery disease requiring lower extremity
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial
ES Debus, MR Nehler, N Govsyeyev, RM Bauersachs… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Patients with peripheral artery disease requiring lower extremity
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial
ES Debus, MR Nehler, N Govsyeyev… - …, 2021 - ingentaconnect.com
Background: Patients with peripheral artery disease requiring lower extremity
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial
ES Debus, MR Nehler, N Govsyeyev… - …, 2021 - research.regionh.dk
BACKGROUND: Patients with peripheral artery disease requiring lower extremity
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial.
ES Debus, MR Nehler, N Govsyeyev, RM Bauersachs… - Circulation, 2021 - europepmc.org
Background Patients with peripheral artery disease requiring lower extremity
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …